With the growing interest in GLP-1 medications for diabetes management and weight management, many people in the Philippines are encountering terms such as semaglutide, tirzepatide, peptides, and research-grade products online. While these terms may sound similar, they do not refer to the same things. Understanding the difference is important when evaluating treatment options and protecting your health.

Through its advocacy, AlaGaan: Alagang Ligtas to Live Lighter promotes access to reliable, understandable information about GLP-1 medications. It helps Filipinos understand how these treatments work, recognize the risks associated with unregistered or unverified products, and make informed decisions with guidance from qualified healthcare professionals.

GLP-1 medications are prescription medicines that act on glucagon-like peptide-1 receptors to help regulate blood sugar and, depending on the specific medicine and its approved indication, support weight management. Although some GLP-1 medicines are peptide-based, not all peptides are GLP-1 medications. Products marketed as research-grade peptides are also different from approved medicines because they may lack the regulatory authorization, manufacturing controls, and safety evidence required for human treatment.

This guide explains the differences, what to know about compounded and research-grade products, and how you can make safer, more informed decisions about GLP-1 treatment in the Philippines.

Why Is There Confusion Around GLP-1 and Peptides in the Philippines?

Interest in GLP-1 treatments has grown as more people learn about their role in managing type 2 diabetes and, for certain approved medicines, supporting weight management.

At the same time, social media, online marketplaces, and other digital platforms have introduced a growing number of terms, including "semaglutide peptide," "tirzepatide peptide," and "research-grade peptides for weight loss."

These terms can make it difficult to distinguish legitimate prescription medicines from products that have not been evaluated or authorized for human use.

For example, a product advertised as containing semaglutide may not necessarily be an authentic, properly manufactured, or FDA-registered medicine. Similarly, a seller's claim that a product has a particular level of purity does not establish that it is safe for injection or appropriate for medical treatment.

This is why understanding what you are buying or considering is essential.

AlaGaan: Alagang Ligtas to Live Lighter advocates for informed health decisions by making reliable GLP-1 information more accessible. Its goal is to help people look beyond online claims, understand potential risks, and know where to find trustworthy information before considering treatment.

What Are Peptides?

Peptides are short chains of amino acids, which are the building blocks of proteins. They occur naturally in the human body and perform different functions, including helping regulate hormones, metabolism, and other biological processes.

Some hormones and signaling molecules in the body are peptides. Others are used as the basis for medicines developed to act on specific biological processes.

Examples of peptide-based hormones and medicines include:

  • Insulin: A hormone that helps regulate blood glucose levels.
  • Glucagon: A hormone that helps raise blood sugar when it becomes too low.
  • Calcitonin: A hormone involved in calcium regulation and bone metabolism.
  • Semaglutide: A synthetic peptide-based medicine that acts on GLP-1 receptors.
  • Liraglutide and dulaglutide: Other peptide-based medicines that act on GLP-1 receptors.

However, being classified as a peptide does not automatically mean a substance is a medicine or is safe for human use.

Peptides can have different structures, functions, and intended applications. Some are used in approved pharmaceutical products, while others are developed for laboratory research and have not been established as safe or effective treatments for people.

Understanding this distinction is particularly important when evaluating products advertised online.

What Are GLP-1 Medications?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally released by the intestines after eating. It helps the body regulate blood sugar and plays a role in appetite and digestion.

GLP-1 receptor agonists are medicines designed to activate the same receptors as the natural GLP-1 hormone.

Depending on the specific medicine, they can help:

  • Stimulate insulin release when blood glucose levels are elevated.
  • Reduce glucagon secretion, which helps regulate blood sugar.
  • Slow down stomach emptying.
  • Influence appetite and feelings of fullness.

These effects help explain why certain GLP-1 medicines are used in managing type 2 diabetes and why some have approved indications for chronic weight management. For a more detailed explanation of how these medicines work, their benefits, available brands, and dosage considerations, read AlaGaan's guide: GLP-1 Medications Explained: Benefits, Brands, Dosage, and How They Work.

What Are Semaglutide and Tirzepatide?

Two commonly discussed active ingredients in this area are semaglutide and tirzepatide. Although both are peptide-based medicines that affect GLP-1 pathways, they work differently.

Semaglutide

Semaglutide is a GLP-1 receptor agonist. It mimics the action of the natural GLP-1 hormone, helping regulate blood sugar, appetite, and food intake.

It is used in different prescription products, depending on the product's approved indication and formulation.

Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It acts on two hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1.

By activating both receptors, it influences blood sugar regulation and appetite-related processes.

The important distinction: Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GIP and GLP-1 receptors. Both are peptide-based medicines, but they are not identical treatments.

Their appropriate use depends on the specific product, its approved indications, and an individual's medical circumstances.

GLP-1 Medications vs. Research-Grade Peptides: What's the Difference?

Not every product marketed as a peptide is a pharmaceutical medicine. Approved GLP-1 medications and research-grade peptides differ significantly in their intended use, regulatory status, and quality assurance.

On smaller screens, scroll across to see all columns.

Approved GLP-1 medicines compared with research-grade peptides
ComparisonApproved GLP-1 medicinesResearch-grade peptides
Intended useApproved medical indicationsLaboratory or scientific research
Human useAuthorized for specified uses, subject to product approvalNot established or authorized for human treatment merely because they are sold
ManufacturingSubject to applicable pharmaceutical quality requirementsQuality controls and manufacturing standards may vary
Quality assuranceSubject to regulatory quality requirementsPurity, identity, strength, and sterility may be unverified
Clinical evidenceSupported by product-specific clinical and regulatory evaluationMay lack adequate human safety and efficacy evidence
AccessThrough appropriate prescription and authorized healthcare channelsOften advertised through online research-chemical vendors

A product's chemical name, advertised purity, or similarity to an approved medicine does not establish that it is safe for human use.

What matters is whether the specific finished medicine has the necessary regulatory authorization, meets applicable quality standards, and is obtained through legitimate healthcare channels.

Why Does Regulatory Approval Matter?

Before a pharmaceutical product can be marketed for human use, it must undergo the applicable regulatory evaluation.

This process considers important factors such as:

  • Product quality and consistency.
  • Safety and effectiveness for its intended use.
  • Manufacturing standards.
  • Product formulation and stability.
  • Appropriate labeling and instructions for use.

In the Philippines, pharmaceutical products intended for human use are subject to the applicable registration requirements of the Food and Drug Administration (FDA).

A Certificate of Product Registration (CPR) is an important part of the Philippine regulatory framework. However, patients should also check whether the establishment supplying the medicine is appropriately licensed.

A product advertised as a "research peptide" should not be treated as an alternative to an authorized prescription medicine.

What Are Compounded Semaglutide and Tirzepatide?

Pharmaceutical compounding refers to the preparation of a customized medication by a qualified pharmacist or other authorized professional, subject to applicable laws and professional requirements.

In certain circumstances, a customized preparation may be considered when a patient has a specific medical need that cannot be adequately addressed by an available commercial product.

However, compounded preparations are not automatically equivalent to commercially approved medicines.

When it comes to semaglutide and tirzepatide, it is important to understand the difference between an authorized pharmaceutical product, a legitimate patient-specific preparation where permitted, and an unapproved product being commercially marketed as an alternative.

Are Compounded GLP-1 Products the Same as Approved Medicines?

No. A compounded preparation should not automatically be considered equivalent to an approved pharmaceutical product.

Differences may involve:

  • Formulation: The ingredients and preparation may differ from those of an approved finished medicine.
  • Quality assurance: The preparation may not have undergone the same product-specific regulatory evaluation as an approved medicine.
  • Stability: Storage requirements and product stability may differ.
  • Dosing: Differences in concentration and preparation can increase the possibility of dosing errors.
  • Clinical evidence: The safety and effectiveness of the specific preparation may not have been established through the same evaluation as the approved product.

Another concern involves salt forms of semaglutide, such as semaglutide sodium or semaglutide acetate. These should not be assumed to be interchangeable with the semaglutide active ingredient used in approved medicines.

The legality and acceptability of any compounded preparation depend on the applicable Philippine regulatory requirements and the specific circumstances of its preparation and use. It is therefore important not to assume that a product is permitted simply because it is described as compounded or prepared by a pharmacy.

For more information, consult the Philippine FDA's Administrative Order No. 2024-0013, which covers the registration of pharmaceutical products and active pharmaceutical ingredients intended for human use. Its effectivity and transitional rules are described in FDA Advisory No. 2025-0030.

Are Research-Grade GLP-1 Peptides Safe to Use?

Research-grade peptides are generally marketed for laboratory or scientific research rather than for human treatment.

Some products carry labels such as "For Research Use Only" or "Not for Human Consumption." These labels indicate that the products are not being presented as medicines authorized for human use.

Using such products for weight loss, diabetes management, or other health purposes can expose individuals to significant risks.

Potential Risks of Using Unverified Research Peptides

  1. Uncertain Product Identity and Purity: A product may not contain the exact substance or concentration advertised by the seller. It may also contain unwanted impurities or undeclared ingredients. Without appropriate testing and quality controls, consumers cannot reliably establish what is in the product.
  2. Contamination and Sterility Concerns: Injectable medicines must meet strict sterility and quality requirements. Products prepared or handled outside appropriate manufacturing controls may be contaminated with microorganisms or other harmful substances. This can result in infections and other complications.
  3. Incorrect Concentration and Dosing: Products sold in powder or liquid vials may have unclear concentrations or instructions. Without reliable product information and appropriate medical supervision, users may administer an incorrect amount, potentially leading to unexpected reactions or inadequate treatment.
  4. Uncertain Stability and Storage: Peptide-based substances can be sensitive to storage conditions. If a product has not undergone appropriate stability testing, its quality and potency may be affected by factors such as temperature, handling, and storage duration.
  5. Lack of Established Human Safety Information: Research-grade products may not have undergone the clinical and regulatory evaluation required for human treatment. This means there may be insufficient information about their potential side effects, interactions, appropriate dosing, and long-term safety.

The risks are particularly concerning when these products are injected or used without medical supervision.

The WHO has also warned about falsified semaglutide products. Its 2024 medical product alert identified specific falsified batches in Brazil, the United Kingdom, and the United States. These cases illustrate why patients should obtain medicines through authorized sources and verify products rather than relying on online claims.

Read the WHO Medical Product Alert on falsified semaglutide.

Red Flags to Watch Out for When Buying GLP-1 Products Online

Online advertisements can make unverified products appear legitimate. Before considering any GLP-1 medication, be aware of these warning signs:

  • Products labeled "For Research Use Only" or "Not for Human Consumption" but advertised for weight loss or diabetes treatment.
  • Sellers offering prescription medicines without requiring an appropriate prescription.
  • Unbranded injectable powders or liquid vials with unclear product information.
  • Claims of guaranteed or unusually rapid weight loss.
  • Products with no verifiable FDA registration details.
  • Sellers who cannot identify the manufacturer, authorized distributor, or source of the medicine.
  • Products that do not match their registered packaging, formulation, or labeling.

Remember that professional-looking packaging, positive online reviews, and claims of high purity do not prove that a medicine is authentic or safe.

If something about a product or seller seems questionable, do not use the product until you have sought appropriate advice and verified its status.

How to Check if a GLP-1 Medication Is Registered in the Philippines

One practical way to protect yourself is to verify a medicine through the official Philippine FDA Verification Portal.

The portal allows the public to check information about registered health products and FDA-licensed establishments.

Steps to Verify a GLP-1 Product

  1. Step 1: Visit the FDA Verification Portal. Go to the official Philippine FDA Verification Portal.
  2. Step 2: Search for the product. Enter the product's brand name, generic name, or registration number.
  3. Step 3: Review the registration details. Check the available information, including product name and active ingredient; dosage form and strength; Certificate of Product Registration number; registration status and validity; and manufacturer, trader, or other relevant company details.
  4. Step 4: Compare the information with the actual product. Make sure the product being offered matches the details in the FDA database. If the information does not match or cannot be verified, do not assume that the product is legitimate.
  5. Step 5: Check the seller or establishment. Product registration and establishment licensing are separate considerations. Check whether the pharmacy or establishment supplying the medicine is appropriately authorized.

An important reminder: A product's registration in another country does not automatically mean it is registered in the Philippines. Regulatory approvals and approved indications can differ between countries.

The FDA Verification Portal should be your starting point when checking a product's local regulatory status. If you are unsure how to interpret the results, ask a pharmacist or healthcare professional for assistance.

For a more detailed walkthrough, read AlaGaan's guide: How to Check if a GLP-1 Medication Is Legitimate in the Philippines.

You can also explore AlaGaan's Stay Safe resources for additional guidance on recognizing potential product risks and understanding product verification.

How to Protect Yourself When Considering GLP-1 Treatment

Making informed decisions about GLP-1 treatment involves more than checking whether a product is registered. It also means understanding your medical needs, obtaining appropriate guidance, and following the correct treatment process.

Here are four important steps to consider.

1. Learn Before You Decide

Take time to understand what GLP-1 medications are, how they work, and what they are intended to treat.

Do not rely solely on social media posts, testimonials, or online advertisements when evaluating a treatment.

Learn about the differences between active ingredients, available formulations, approved uses, and possible risks.

Through AlaGaan's Educational Resources, you can explore information about GLP-1 medications, treatment considerations, and patient safety.

For a more comprehensive introduction, read GLP-1 Medications Explained: Benefits, Brands, Dosage, and How They Work.

2. Verify Every Product

Before considering a GLP-1 medicine, check its registration through the Philippine FDA Verification Portal.

Avoid purchasing prescription medicines from unauthorized online vendors, social media sellers, or unverified marketplaces.

Be particularly cautious of products marketed as research chemicals or products that cannot provide verifiable registration and manufacturer information.

AlaGaan's Stay Safe resources provide guidance to help individuals recognize potential warning signs and understand how to check product legitimacy.

You can also follow the step-by-step instructions in How to Check if a GLP-1 Medication Is Legitimate in the Philippines.

3. Consult a Qualified Healthcare Professional

GLP-1 medicines are not suitable for everyone. Their use requires an appropriate medical assessment to determine whether a particular treatment is suitable for an individual's health needs.

A licensed physician can help assess:

  • Whether the medication is appropriate for your condition.
  • Your medical history and existing health concerns.
  • Potential side effects and contraindications.
  • Other medications you are taking.
  • The appropriate treatment plan and monitoring requirements.

Never start, change, or stop a prescribed GLP-1 medication without discussing it with your healthcare provider.

If you have questions about GLP-1 treatment, you can visit AlaGaan Ask a Doctor to submit a general health question through its review channel.

4. Follow the Prescribed Treatment and Storage Instructions

If your physician prescribes a GLP-1 medication, follow the product-specific instructions carefully.

These may include:

  • Following the prescribed dosage and administration schedule.
  • Understanding how to use the injection device, if applicable.
  • Observing the recommended storage conditions.
  • Attending follow-up consultations.
  • Reporting unexpected side effects to your healthcare provider.

Different GLP-1 products may have different storage requirements. Do not assume that all medicines require the same refrigeration conditions. Always follow the product's official labeling and your healthcare professional's instructions.

Proper use and ongoing medical guidance are important parts of maintaining treatment safety.

How AlaGaan Helps Filipinos Make Informed and Safer GLP-1 Decisions

Understanding GLP-1 medications is only the first step. Knowing how to identify legitimate products, recognize potential risks, and seek appropriate medical guidance is equally important.

This is the purpose behind AlaGaan: Alagang Ligtas to Live Lighter, a public information and patient-safety advocacy dedicated to helping Filipinos make informed decisions about GLP-1 medications.

AlaGaan recognizes that the growing availability of health information online can make it difficult for people to distinguish reliable medical information from misleading claims. Its role is to make essential information easier to understand and help individuals navigate their GLP-1 journey with greater awareness.

Through its resources and educational initiatives, AlaGaan focuses on four important areas:

1. Making GLP-1 Information Easier to Understand

AlaGaan provides accessible educational information about GLP-1 medications, their uses, how they work, and important treatment considerations.

By explaining medical topics in clear, understandable language, it helps individuals become more informed before discussing treatment with a healthcare professional.

Explore the AlaGaan Learn section for more educational articles and resources, including GLP-1 Medications Explained.

2. Helping People Recognize Product Risks

Not every product advertised online is a legitimate or authorized medicine.

AlaGaan helps raise awareness about counterfeit, unregistered, and unverified products, including research-grade substances marketed for human use.

Its patient-safety resources encourage individuals to recognize warning signs and understand why product verification matters.

Visit AlaGaan Stay Safe to learn more about product safety and verification.

3. Encouraging Questions and Medical Guidance

AlaGaan encourages individuals to seek appropriate medical advice instead of relying on online sellers, unverified recommendations, or self-prescribed treatments.

Through its Ask a Doctor platform, the advocacy provides a way for people to submit general questions for review.

The goal is to encourage informed conversations between patients and qualified healthcare professionals.

4. Promoting Responsible and Informed Health Decisions

AlaGaan does not sell, supply, prescribe, or endorse specific pharmaceutical products. Its focus is on public education and patient safety.

It encourages individuals to understand their options, verify product information through official sources, and seek appropriate medical guidance before making treatment decisions.

Whether you are learning about GLP-1 medications for the first time or already considering treatment, AlaGaan aims to help you approach your health decisions with reliable information and greater confidence.

Alagang Ligtas to Live Lighter means putting informed decisions and patient safety first.

Frequently Asked Questions About GLP-1 and Peptides

What is the difference between GLP-1 medications and peptides?

Peptides are a broad group of molecules made up of amino acids. GLP-1 medications are a specific group of prescription medicines that act on GLP-1 receptors to help regulate blood sugar and, depending on the product, support weight management. Some GLP-1 medicines are peptide-based, but not all peptides are GLP-1 medications.

Is semaglutide a peptide?

Yes. Semaglutide is a synthetic peptide-based medicine that acts as a GLP-1 receptor agonist. It is used in approved prescription products for specific medical indications. However, not all products advertised as semaglutide are necessarily authentic or authorized for human use.

Is tirzepatide a GLP-1 medication?

Tirzepatide acts on both GIP and GLP-1 receptors, making it a dual GIP and GLP-1 receptor agonist. Although it affects GLP-1 pathways, it is pharmacologically different from medicines such as semaglutide, which act specifically on GLP-1 receptors.

Are all peptides safe for human use?

No. Peptides have different structures, functions, and intended uses. Some are used in approved pharmaceutical products, while others are intended for laboratory research and have not been established as safe or effective treatments for people. A product's classification as a peptide does not automatically make it safe for human use.

What are research-grade peptides?

Research-grade peptides are substances marketed for laboratory or scientific research. They may carry labels such as "For Research Use Only" or "Not for Human Consumption." These products should not be treated as approved medicines or used for self-treatment.

Is compounded semaglutide the same as approved semaglutide?

No. A compounded preparation is not automatically equivalent to an approved pharmaceutical product. Differences may include formulation, manufacturing controls, stability, quality assurance, and the level of clinical and regulatory evaluation. The acceptability of a compounded preparation depends on applicable regulations and the specific circumstances of its preparation and use.

Are compounded GLP-1 medications allowed in the Philippines?

The regulatory status of a compounded preparation depends on applicable Philippine laws, FDA requirements, and the specific circumstances involved. Administrative Order No. 2024-0013 establishes registration requirements for pharmaceutical products intended for human use, but it should not be interpreted as a blanket ruling on every form of pharmaceutical compounding. Patients should consult the FDA or a qualified regulatory professional for clarification.

How can I check if a GLP-1 medication is FDA-registered in the Philippines?

Visit the Philippine FDA Verification Portal. Search using the product's brand name, generic name, or registration number. Review its registration status, formulation, strength, and other available details. You should also verify that the establishment supplying the medicine is appropriately licensed. For more guidance, read How to Check if a GLP-1 Medication Is Legitimate in the Philippines.

Can I buy GLP-1 medications online without a prescription?

GLP-1 medicines classified as prescription drugs should be obtained through appropriate prescription and authorized dispensing channels. Avoid online sellers who offer prescription medicines without requiring the necessary medical documentation or who cannot provide verifiable product information.

What should I do if I suspect that a GLP-1 product is counterfeit or unregistered?

Do not use a product that you suspect may be counterfeit or unregistered. Keep its packaging and available purchase details, and seek guidance from a healthcare professional or the Philippine FDA. You may also email report@alagaan.org for guidance on reporting, providing relevant product, seller, and purchase information. Submit suspected regulatory violations directly through the Philippine FDA eSumbong system. If you have already used the product and experience an unexpected reaction, seek medical advice promptly and follow the Philippine FDA patient pharmacovigilance guidance.

Make Informed Choices With AlaGaan: Alagang Ligtas to Live Lighter

Understanding the difference between GLP-1 medications, peptides, compounded preparations, and research-grade products is an important step toward making safer health decisions.

When considering GLP-1 treatment, do not rely solely on online claims, product advertisements, or promises of quick results. Take time to understand the medication, verify the product through official sources, and seek guidance from a qualified healthcare professional.

Through AlaGaan: Alagang Ligtas to Live Lighter, you can access educational resources, learn how to recognize potential product risks, and find guidance to help you make informed decisions about GLP-1 medications.

Your health deserves accurate information, proper guidance, and responsible care.

Inform. Verify. Ask.

Explore AlaGaan's Educational Resources

Learn How to Stay Safe

Read: GLP-1 Medications Explained

Read: How to Check if a GLP-1 Medication Is Legitimate in the Philippines

Ask a Doctor

Sources and References

These sources support the educational and product-safety information in this article. Regulatory status, product approvals, and clinical guidance can change.

Philippine regulatory references

  1. Philippine Food and Drug Administration — Administrative Order No. 2024-0013. General rules and regulations on registration of pharmaceutical products and active pharmaceutical ingredients intended for human use.
  2. Philippine Food and Drug Administration — Advisory No. 2025-0030. Effectivity of Administrative Order No. 2024-0013 and treatment of current certificates and pending implementing guidelines.
  3. Philippine Food and Drug Administration — Verification Portal. Public entry point for checking registered health products and licensed establishments.
  4. Philippine Food and Drug Administration — eSumbong reporting portal for suspected product or seller violations.
  5. Philippine Food and Drug Administration — Patient pharmacovigilance and adverse-event reporting guidance.

The U.S. FDA sources describe U.S. regulatory context and should not be treated as confirmation of Philippine registration or approved indications. Philippine FDA registration and establishment licensing are separate checks, and neither one by itself authenticates an individual pack or vial. Always consult a licensed healthcare professional about treatment decisions.